About Chiltern International
Chiltern International is a Healthcare company based in United States founded in 1982, and was acquired by LabCorp in September 2017. Full service CRO with expertise in oncology related development services. Chiltern International has completed 4 acquisitions, including Chiltern, Integrated Development Associates and Pacific Clinical Research. Its Indian entity Chiltern International Private Limited reported revenue of βΉ2.70 Cr. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Emmes, Syneos Health and Veristat.
Company details
Chiltern is a full-service CRO focussed on providing clinical research development services in a variety of specialty areas and engagement models for biotech, pharma, biopharma, medical device and diagnostics industries. It provides a suite of services in clinical development, medical scientific affairs, data analysis, pharmacovigilance, strategic regulatory and clinical supplies. It is currently operating in 47 countries with 22,000 investigation sites claims to have conducted 1,800clinical trials. Chilterns offerings are focused on three major areas - Chiltern Oncology (Oncology CRO services across all phases of development), Chiltern Biopharmaceutics (Global CRO services with therapeutic experience in respiratory, ophthalmology, infectious disease, vaccines and dermatology) , Chiltern Source (Functional Services and Sourcing solutions specializing in customized sourcing solutions for clinical, regulatory, medical and biometrics services.
- Headquarters Berkshire County, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website chiltern.com
- Social LinkedIn X Facebook
- Acquired by LabCorp (Sep 2017)
- Legal Name Chiltern International Private Limited
- Date of Incorporation 01 Feb, 2005
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Chiltern International
Chiltern International operates through Chiltern International Private Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2017) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Chiltern International Private Limited CIN U73100MH2005PTC150926 | Amalgamated | 01 Feb 2005 | Mumbai, Maharashtra | ₹2.7 Cr | 28 | 3 | View details |
Funding Insights of Chiltern International
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Chiltern International with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2010 | Private Equity Round | β | β |
3 investors in total: 3 institutional.
Investors in Chiltern International
Chiltern International has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Kester Capital and Czura Thornton.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kester Capital is focused on private equity investments in technology and life sciences sectors. | kestercapital.com | London, United Kingdom | ||
| czurathornton.com | ||||
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for Chiltern International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Chiltern International Private Limited (Chiltern International)
Chiltern International Private Limited is the primary company behind Chiltern International. The board of Chiltern International Private Limited currently have 3 directors; the longest-serving is Sandeep Adsule Dada, appointed in 2012. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandeep Adsule Dada DIN 05342475 | Director | 29 Aug 2012 | 14 yrs 2 mo | Chiltern International Private Limited |
| Linda Josephine Green DIN 06457445 | Director | 21 Dec 2012 | 13 yrs 10 mo | Chiltern International Private Limited |
| Richard Timothy Barfield DIN 06763918 | Director | 21 Dec 2013 | 12 yrs 10 mo | Chiltern International Private Limited |
Financials of Chiltern International
Figures of Chiltern International Private Limited, the primary company behind Chiltern International, for FY 2017. Revenue was ₹2.70 Cr (-58% year on year). Net loss was -₹72.4 Lakh (-18% margin). EBITDA was -₹45 Lakh (-11% margin).
- ₹2.70 CrRevenue · FY 2017 · -58% YoY
- -₹72.4 LakhNet loss · -18% margin
- -₹45 LakhEBITDA · -11% margin
- ₹32.8 LakhPaid-up capital
- 28Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Chiltern International Private Limited are on its company page.
Detailed financial statements for Chiltern International
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chiltern International
Chiltern International has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Chiltern, Integrated Development Associates and Pacific Clinical Research.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Full-service CRO, based out of Japan and Asia and also offering regulatory consulting services | i-d-a.com | Tokyo, Japan | 2004 | May 2017 | β’β’β’β’ | |
Clinical development services for biopharma and medical devices are provided. | theoremclinical.com | King Of Prussia, United States | 1985 | Aug 2015 | β’β’β’β’ | |
Clinical trial management services are provided across Asian markets. | pacificcro.com | Mumbai, India | 2009 | Sep 2014 | β’β’β’β’ | |
Full-service oncology CRO operations are conducted globally. | ockham.com | Sacramento, United States | 1986 | Jul 2014 | β’β’β’β’ |
Complete acquisition details for Chiltern International
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Chiltern International
8 dated milestones of Chiltern International across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Chiltern International is founded.
- Exit Acquired by Czura Thornton.
- Funding First funding round.
- Acquisition Acquires Chiltern.
- Acquisition Acquires Pacific Clinical Research.
- Acquisition Acquires Theorem Clinical Research.
- Acquisition Acquires Integrated Development Associates.
- Exit Acquired by LabCorp.
Competitors of Chiltern International
Chiltern International has 3 listed competitors in our database. They include Emmes, Syneos Health and Veristat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | 195 | Outsourced contract research organization services are provided to clients. | ||
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| veristat.com | 1994 | Southborough, United States | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of Chiltern International
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Chiltern International
Websites that share an audience with Chiltern International (chiltern.com).
Websites whose visitors overlap most with Chiltern International. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| richmondpharmacology.com | 100% | 8.1K | #4,561,453 | View details | |
| illingworthresearch.com | 99% | 1.2K | #11,172,207 | View details | |
| pharm-olam.com | 92% | View details | |||
acr-research.com | acr-research.com | 85% | β | ||
| premier-research.com | 85% | 39.9K | #825,378 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 23 similar websites and full traffic analytics for Chiltern International
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Chiltern International (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chiltern International
Complete news archive for Chiltern International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiltern International
Chiltern International was founded in 1982 and raised its 1st funding round 28 years after it was founded.
Chiltern International is headquartered in United States. It is registered at Massachusetts, United States.
The primary company behind Chiltern International, Chiltern International Private Limited, reported revenue of βΉ2.70 Cr for FY 2017, down 58% year on year.
Chiltern is a full-service CRO focussed on providing clinical research development services in a variety of specialty areas and engagement models for biotech, pharma, biopharma, medical device and diagnostics industries. It provides a suite of services in clinical development, medical scientific affairs, data analysis, pharmacovigilance, strategic regulatory and clinical supplies. It is currently operating in 47 countries with 22,000 investigation sites claims to have conducted 1,800clinical trials. Chilterns offerings are focused on three major areas - Chiltern Oncology (Oncology CRO services across all phases of development), Chiltern Biopharmaceutics (Global CRO services with therapeutic experience in respiratory, ophthalmology, infectious disease, vaccines and dermatology) , Chiltern Source (Functional Services and Sourcing solutions specializing in customized sourcing solutions for clinical, regulatory, medical and biometrics services.
Chiltern International's top competitors include Emmes, Syneos Health and Veristat.
Chiltern International has made 4 acquisitions, including Chiltern, Integrated Development Associates, and Pacific Clinical Research.
Chiltern International has 3 investors. Key investors include LabCorp, Kester Capital, and Czura Thornton.
Chiltern International operates through Chiltern International Private Limited.
Yes. Chiltern International was acquired by LabCorp in September 2017.
The legal entities of Chiltern International currently have 3 directors, including Sandeep Adsule Dada, Linda Josephine Green, Richard Timothy Barfield.

